StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SANO1.TA$40340.00-2.02%
Fair $40340.00+0.0%

SANO1.TA

Sano Bruno's Enterprises Ltd

Consumer Defensive / Household & Personal ProductsTel Aviv

$40340.00

-830.00 (-2.02%)

Fairly Valued+0.0%Fair Value $40340.00Fund rank 33/100 · Data gapFallback financials|
SA 50/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $101.5M · quality 66.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 57/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SANO1.TALocal privado en este navegador · Sano Bruno's Enterprises Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.5B

P/E

15.5x

↑

EV/EBITDA

1109.9x

↑

ROE

12.7%

↑

Gross Margin

37.1%

↑

Debt/Equity

0.02

↓
52-Week Range$40340
$29170$46400

TradingView lightweight chart

SANO1.TA price, volumen y niveles de valoración

Último $40,340Periodo +1444.4%
Fair value: $40,340

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.4%

FCF CAGR

+25.1%

FCF margin

3.5%

FCF / Net income

0.28x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.24B · net income $282.2M · FCF $79.0M

2022-FY → 2025-FY

Gross margin

37.1%+3.6% pts

Operating margin

15.1%+5.3% pts

Net margin

12.6%+5.1% pts

FCF margin

3.5%+1.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.24B$2.24B$2.27B$2.13B$1.91B
Net Income$282.2M$282.2M$263.5M$237.6M$144.0M
EBITDA$408.3M$408.3M$390.6M$350.4M$232.5M
EPS——21.1312.8112.81
Gross Margin37.1%37.1%37.8%36.7%33.5%
Operating Margin15.1%15.1%14.0%13.3%9.9%
Net Margin12.6%12.6%11.6%11.2%7.5%
Balance Sheet
Debt/Equity0.020.020.020.020.02
Current Ratio3.313.31———
Cash Flow
Free Cash Flow$79.0M$79.0M$101.5M$178.4M$40.3M
Returns
ROE12.7%12.7%13.1%12.5%8.5%
Valuation
P/E15.4615.461650.262170.181850.90
EV/EBITDA1109.921109.921002.70890.351145.27
P/B204.40204.40194.98164.53156.94
Growth & Yield
Revenue Growth-1.5%-1.5%6.8%11.3%—
EPS Growth——64.9%0.0%—
Dividend Yield1.4%1.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +29.6%

Total return

+29.6%

Start / end P/E

n/dx → n/dx

EPS bridge

21.13 → n/d

Residual

+28.2%

EPS growthn/d
Multiple reratingn/d
Dividend+1.4%
Residual / FX / buybacks / cross-term+28.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.